FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment.

The post FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug appeared first on InvestorPlace.

• ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors